|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1995-3-28
|
|
pubmed:abstractText |
In more than 40% of patients with fibromyalgia a marked influence on the pain in the skeletal system with a decrease of the tenderness at "tenderpoints" can be achieved by blocking the 5-HT3-receptors with ondansetron or tropisetron-hydrochloride. Physical complaints and vegetative signs also improve. It is discussed if patients not responding to therapy with ondansetron or tropisetron-hydrochloride have to be discriminated as a subgroup of fibromyalgia. More investigations are needed to confirm the described effects.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0340-1855
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
335-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7871905-Acetaminophen,
pubmed-meshheading:7871905-Cross-Over Studies,
pubmed-meshheading:7871905-Dose-Response Relationship, Drug,
pubmed-meshheading:7871905-Drug Administration Schedule,
pubmed-meshheading:7871905-Fibromyalgia,
pubmed-meshheading:7871905-Humans,
pubmed-meshheading:7871905-Indoles,
pubmed-meshheading:7871905-Ondansetron,
pubmed-meshheading:7871905-Pain Measurement,
pubmed-meshheading:7871905-Receptors, Serotonin,
pubmed-meshheading:7871905-Serotonin Antagonists
|
|
pubmed:articleTitle |
[Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors].
|
|
pubmed:affiliation |
Hochrhein-Institut für Rehabilitationsforschung, Bad Säckingen.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|
